作者 Wu, Xiao-ning; Yu, Chen-huan; Cai, Wei; Hua, Jian; Li, Shi-qing; Wang, Wei
期刊 JOURNAL OF ETHNOPHARMACOLOGY , MAR 8 2011,1:134
DOI 10.1016/j.jep.2010.11.074 PubMed 21146600
摘要 Ethnopharmacological relevance: Magnolia officinalis bark is used in traditional Chinese medicine for the treatment of cough, colds, fever, chronic bronchitis and stomach ailments.Aim of the study: To investigate therapeutic effects of polyphenol rich extract from M. officinalis bark (MPE) in influenza virus A-infected mice, and to provide evidence for the inflammation response and immunomodulatory potential during infection.Materials and methods: Mice were infected with influenza virus A (IVA) and MPE at doses of 10 and 20 mg/kg were orally administrated daily for 5 days after challenge. The levels of serum L-6 and TNF-alpha were determined by ELISA while protein expressions of NF-kappa B and TLR3 were detected by western blotting analysis.Results: MPE exhibited significant therapeutical effects on reducing levels of serum NO, IL-6 and TNF-alpha, inhibiting pneumonia, decreasing lung viral titers and sensitizing IVA-induced apoptosis through down-regulation of NF-kappa B and TLR3 protein expression in the lung tissue of IVA-infected mice.Conclusions: MPE could exhibit preventive and therapeutical effects on IVA-infected mice as a suppressor of the production of inflammatory mediators, NO and pro-inflammatory cytokines, TNF-alpha and IL-6. These effects appeared to be mediated, at least in part, by an inhibition of TLR3 and NF-kappa B activation. Therefore. MPE could provide a safe and effective therapeutic approach for influenza and its subsequent viral pneumonia. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
版权所有 Copyright © 2002-2025 中国科学院昆明植物研究所,All Rights Reserved 【滇ICP备05000394号】
地址:中国云南省昆明市蓝黑路132号 邮政编码:650201 点击这里联系我们